Cargando…

Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy

BACKGROUND: Diabetic nephropathy is a major complication of diabetes and an established risk factor for cardiovascular events. Lipid abnormalities occur in patients with diabetic nephropathy, which further increase their risk for cardiovascular events. We compared the degree of dyslipidemia among ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palazhy, Sabitha, Viswanathan, Vijay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409011/ https://www.ncbi.nlm.nih.gov/pubmed/28447439 http://dx.doi.org/10.4093/dmj.2017.41.2.128

Ejemplares similares

Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study
por: Viswanathan, Vijay, et al.
Publicado: (2012)

Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus Patients with and without Nephropathy
por: Kumawat, Manjulata, et al.
Publicado: (2013)

Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
por: Peppa, Melpomeni, et al.
Publicado: (2011)

Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy
por: Araki, Hisazumi, et al.
Publicado: (2013)

A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes
por: Wadén, Johan, et al.
Publicado: (2009)

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy
por: Pelletier, Karyne, et al.
Publicado: (2019)

Profile of type 2 diabetes mellitus without overt complications of diabetes mellitus at a tertiary care center
por: Singla, Rajiv, et al.
Publicado: (2012)

Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy
por: Vanaie, Azam, et al.
Publicado: (2019)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Abnormal Angiogenesis in Diabetic Nephropathy
por: Nakagawa, Takahiko, et al.
Publicado: (2009)

Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes
por: Tanaka, Kentaro, et al.
Publicado: (2015)

Association of urinary albumin-to-creatinine ratio with lipid abnormalities and glycemic control in patients with type 2 diabetes mellitus
por: Khadka, Sitaram, et al.
Publicado: (2023)

Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus
por: Hu, Fan, et al.
Publicado: (2020)

Haematological parameters and lipid profile abnormalities among patients with Type-2 diabetes mellitus in Ghana
por: Antwi-Baffour, Samuel, et al.
Publicado: (2018)

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
por: Imai, E., et al.
Publicado: (2011)

Diffuse myocardial fibrosis and early strain abnormalities in asymptomatic type 2 diabetics without overt cardiovascular disease
por: Schmidt, Anna, et al.
Publicado: (2015)

A study on the association of diabetic dermopathy with nephropathy and retinopathy in patients with type 2 diabetes mellitus
por: Mirhoseini, Mahmoud, et al.
Publicado: (2016)

The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus
por: Okeoghene, Ogbera A., et al.
Publicado: (2013)

AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients
por: Rahimi, Zohreh, et al.
Publicado: (2013)

Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Elsheikh, Mohamed, et al.
Publicado: (2019)

Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus
por: De Muro, Pierina, et al.
Publicado: (2016)

Influence of Overt Diabetes Mellitus on Cyclosporine Pharmacokinetics in a Canine Model
por: Alkharfy, Khalid M.
Publicado: (2009)

AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy
por: Moradi, Mahmoudreza, et al.
Publicado: (2015)

Mannose-binding lectin activation is associated with the progression of diabetic nephropathy in type 2 diabetes mellitus patients
por: Cai, Kedan, et al.
Publicado: (2020)

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study
por: Bichu, Prasad, et al.
Publicado: (2009)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
por: Baek, Jong Ha, et al.
Publicado: (2021)

Urinary nephrin linked nephropathy in type-2 diabetes mellitus
por: Rangaswamaiah, Hareesh, et al.
Publicado: (2022)

The Association of Pulmonary Tuberculosis, Abnormal Glucose Tolerance, and Type 2 Diabetes Mellitus: A Hospital-Based Cross-Sectional Study
por: CA, Jayashankar, et al.
Publicado: (2021)

Overt Diabetes in Pregnancy
por: Goyal, Alpesh, et al.
Publicado: (2022)

Electrophysiological abnormalities in patients with paroxysmal atrial fibrillation in the absence of overt structural heart disease
por: Arroja, José David, et al.
Publicado: (2016)

Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
por: Shigematsu, Erina, et al.
Publicado: (2014)

Brainstem Auditory Evoked Potential Abnormalities in Type 2 Diabetes Mellitus
por: Gupta, Sharat, et al.
Publicado: (2013)

Detection of Hemostasis Abnormalities in Type 2 Diabetes Mellitus Using Thromboelastography
por: Arsana, Putu Moda, et al.
Publicado: (2022)

Zebrafish: A Model to Study and Understand the Diabetic Nephropathy and Other Microvascular Complications of Type 2 Diabetes Mellitus
por: Sharchil, Charles, et al.
Publicado: (2022)

Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature
por: Thipsawat, Sopida
Publicado: (2021)

Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
por: Song, Ki‐Ho, et al.
Publicado: (2018)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

Vitamin D deficiency increases risk of nephropathy and cardiovascular diseases in Type 2 diabetes mellitus patients
por: Aljack, Hala Abdalazeem, et al.
Publicado: (2019)

Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure)
por: Imai, Enyu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hjckqvn9696pkglctf6kds2oar